DepoProvera
Organization of Teratology Information Specialists, 2004
For more information regarding OTIS or a Teratology Information Service in your area, call OTIS Information at (866) 626-6847 or visit us online at: www.OTISpregnancy.org.
The information below will help you determine if Depo Provera exposure during pregnancy represents an increased fetal risk.
Pharmacodynamic effects of depot-lprogesterone acetate (DMPA) administered to lactating women on their male infants.
View rest of article at otispregnancy.org «
Related articles
Below are some of our articles related to the article above:
The TRIP Database is a clinical search tool designed to allow health professionals to rapidly identify the highest quality clinical evidence for clinical practice.
Registered users (registration is free) benefit from extra features such as CPD, search history, and collaborative tools. Register here, or Login if you have registered before.
Find out more about Trip Database.
